These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

504 related items for PubMed ID: 29024498

  • 1. Feasibility and efficiency of concurrent chemoradiotherapy with capecitabine and cisplatin versus radiotherapy alone for elderly patients with locally advanced esophageal squamous cell carcinoma: Experience of two centers.
    Chen F, Luo H, Xing L, Liang N, Xie J, Zhang J.
    Thorac Cancer; 2018 Jan; 9(1):59-65. PubMed ID: 29024498
    [Abstract] [Full Text] [Related]

  • 2. Definitive chemoradiotherapy with capecitabine and cisplatin for elder patients with locally advanced squamous cell esophageal cancer.
    Xing L, Liang Y, Zhang J, Wu P, Xu D, Liu F, Yu X, Jiang Z, Song X, Zang Q, Wang W.
    J Cancer Res Clin Oncol; 2014 May; 140(5):867-72. PubMed ID: 24578238
    [Abstract] [Full Text] [Related]

  • 3. Comparison of concurrent chemoradiotherapy with radiotherapy alone for locally advanced esophageal squamous cell cancer in elderly patients: A randomized, multicenter, phase II clinical trial.
    Liu Y, Zheng Z, Li M, Zhang Y, Zhao F, Gong H, Lin H, Huang W, Chen X, Xu Z, Li X, Liu W, Cui Y, Zheng A, Li B.
    Int J Cancer; 2022 Aug 15; 151(4):607-615. PubMed ID: 35419831
    [Abstract] [Full Text] [Related]

  • 4. Is there a benefit in receiving concurrent chemoradiotherapy for elderly patients with inoperable thoracic esophageal squamous cell carcinoma?
    Zhang P, Xi M, Zhao L, Shen JX, Li QQ, He LR, Liu SL, Liu MZ.
    PLoS One; 2014 Aug 15; 9(8):e105270. PubMed ID: 25133495
    [Abstract] [Full Text] [Related]

  • 5. Feasibility and efficiency of concurrent chemoradiotherapy with a single agent or double agents vs radiotherapy alone for elderly patients with esophageal squamous cell carcinoma: Experience of two centers.
    Huang C, Zhu Y, Li Q, Zhang W, Liu H, Zhang W, Hu Y, Yuan Y, Liu M.
    Cancer Med; 2019 Jan 15; 8(1):28-39. PubMed ID: 30600600
    [Abstract] [Full Text] [Related]

  • 6. Clinical Effect of Radiotherapy Combined with Chemotherapy for Non-Surgical Treatment of the Esophageal Squamous Cell Carcinoma.
    Chen H, Zhou L, Yang Y, Yang L, Chen L.
    Med Sci Monit; 2018 Jun 19; 24():4183-4191. PubMed ID: 29915168
    [Abstract] [Full Text] [Related]

  • 7. Concurrent chemoradiotherapy with S-1 compared with concurrent chemoradiotherapy with docetaxel and cisplatin for locally advanced esophageal squamous cell carcinoma.
    Zhou XL, Yu CH, Wang WW, Ji FZ, Xiong YZ, Zhu WG, Tong YS.
    Radiat Oncol; 2021 May 26; 16(1):94. PubMed ID: 34039375
    [Abstract] [Full Text] [Related]

  • 8. Dose escalation intensity-modulated radiotherapy-based concurrent chemoradiotherapy is effective for advanced-stage thoracic esophageal squamous cell carcinoma.
    Chang CL, Tsai HC, Lin WC, Chang JH, Hsu HL, Chow JM, Yuan KS, Wu ATH, Wu SY.
    Radiother Oncol; 2017 Oct 26; 125(1):73-79. PubMed ID: 28923576
    [Abstract] [Full Text] [Related]

  • 9. Concurrent chemoradiotherapy with twice weekly paclitaxel and cisplatin followed by esophagectomy for locally advanced esophageal cancer.
    Lin CC, Hsu CH, Cheng JC, Wang HP, Lee JM, Yeh KH, Yang CH, Lin JT, Cheng AL, Lee YC.
    Ann Oncol; 2007 Jan 26; 18(1):93-98. PubMed ID: 17028244
    [Abstract] [Full Text] [Related]

  • 10. The crucial role of blood VEGF kinetics in patients with locally advanced esophageal squamous cell carcinoma receiving curative concurrent chemoradiotherapy.
    Chen YH, Lu HI, Lo CM, Wang YM, Chou SY, Hsiao CC, Huang CC, Shih LH, Chen SW, Li SH.
    BMC Cancer; 2018 Aug 20; 18(1):837. PubMed ID: 30126380
    [Abstract] [Full Text] [Related]

  • 11. Definite intensity-modulated radiotherapy with concurrent chemotherapy more than 4 cycles improved survival for patients with locally-advanced or inoperable esophageal squamous cell carcinoma.
    Hsieh HY, Hsu CP, Yeh HL, Chuang CY, Lin JF, Chang CF.
    Kaohsiung J Med Sci; 2018 May 20; 34(5):281-289. PubMed ID: 29699635
    [Abstract] [Full Text] [Related]

  • 12. Phase I study of concurrent selective lymph node late-course accelerated hyperfractionated radiotherapy and S-1 plus cisplatin for locally advanced oesophageal squamous cell carcinoma.
    Li M, Fu C, Zhang W, Huang W, Wang Z, Zhou T, Lin H, Li B.
    Br J Radiol; 2016 May 20; 89(1060):20150476. PubMed ID: 26891913
    [Abstract] [Full Text] [Related]

  • 13. Esophageal Metal Stents with Concurrent Chemoradiation Therapy for Locally Advanced Esophageal Cancer: Safe or Not?
    Lu YF, Chung CS, Liu CY, Shueng PW, Wu LJ, Hsu CX, Kuo DY, Hou PY, Chou HL, Leong KI, How CH, Chou SF, Wang LY, Hsieh CH.
    Oncologist; 2018 Dec 20; 23(12):1426-1435. PubMed ID: 29728468
    [Abstract] [Full Text] [Related]

  • 14. Preoperative low-dose weekly cisplatin and continuous infusion fluorouracil plus hyperfractionated radiotherapy in stage II-III esophageal carcinoma.
    Caro M, Font A, Comas S, Viciano M, Remon J, Céliz P, Robles J, Musulén E, Sendrós MJ, Mesalles E, Jiménez JA, Boix J, Arellano A, Fernández-Llamazares J.
    Clin Transl Oncol; 2016 Nov 20; 18(11):1106-1113. PubMed ID: 26856597
    [Abstract] [Full Text] [Related]

  • 15. Concurrent chemoradiotherapy for locally advanced esophageal cancer--a pilot study by using daily low-dose cisplatin and continuous infusion of 5-fluorouracil.
    Hsu CH, Yeh KH, Lui LT, Lee YC, Bu CF, Wang HP, Lin JT, Cheng AL.
    Anticancer Res; 1999 Nov 20; 19(5C):4463-7. PubMed ID: 10650793
    [Abstract] [Full Text] [Related]

  • 16. Weekly Chemotherapy of 5-Fluorouracil plus Cisplatin Concurrent with Radiotherapy for Esophageal Squamous Cell Carcinoma Patients with Postoperative Locoregional Recurrence: Results from a Phase II Study.
    Chen B, Li Q, Li Q, Qiu B, Xi M, Liu M, Hu Y, Zhu Y.
    Oncologist; 2020 Apr 20; 25(4):308-e625. PubMed ID: 31880371
    [Abstract] [Full Text] [Related]

  • 17. Comparison of cisplatinum/paclitaxel with cisplatinum/5-fluorouracil as first-line therapy for nonsurgical locally advanced esophageal squamous cell carcinoma patients.
    Hu G, Wang Z, Wang Y, Zhang Q, Tang N, Guo J, Liu L, Han X.
    Drug Des Devel Ther; 2016 Apr 20; 10():2129-36. PubMed ID: 27445460
    [Abstract] [Full Text] [Related]

  • 18. Outcomes of concurrent chemoradiotherapy versus chemotherapy alone for stage IV esophageal squamous cell carcinoma: a retrospective controlled study.
    Lyu J, Li T, Wang Q, Li F, Diao P, Liu L, Li C, Lang J.
    Radiat Oncol; 2018 Nov 26; 13(1):233. PubMed ID: 30477531
    [Abstract] [Full Text] [Related]

  • 19. Comparison of Definitive Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma.
    Yao B, Tan B, Wang C, Song Q, Wang J, Guan S, Jia Y, Ma Y, Huang X, Sun Y, Cheng Y.
    Ann Surg Oncol; 2016 Jul 26; 23(7):2367-72. PubMed ID: 26932711
    [Abstract] [Full Text] [Related]

  • 20. Concurrent weekly cisplatin versus triweekly cisplatin with radiotherapy for locally advanced squamous-cell carcinoma of the cervix: a retrospective analysis from a single institution.
    Kinjyo Y, Nagai Y, Toita T, Kudaka W, Ariga T, Shimoji Y, Nakasone T, Taira Y, Arakaki Y, Nakamoto T, Wakayama A, Ooyama T, Maemoto H, Heianna J, Aoki Y.
    Br J Radiol; 2017 Aug 26; 90(1076):20170241. PubMed ID: 28707541
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.